Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Japan.
Department of Rheumatology, Saku Central Hospital, Saku, Japan.
Sci Rep. 2022 Apr 26;12(1):6787. doi: 10.1038/s41598-022-10932-3.
Adult-onset Still's disease (AOSD)-a systemic inflammatory disease-often occurs at a young age. Recently, elderly onset patient proportion has been increasing; however, data are limited. To evaluate the characteristics of elderly patients with AOSD in a multicenter cohort, we retrospectively analyzed 62 patients with AOSD at five hospitals during April 2008-December 2020. Patients were divided into two groups according to age at disease onset: younger-onset (≤ 64 years) and elderly onset (≥ 65 years). Clinical symptoms, complications, laboratory findings, treatment, and outcomes were compared. Twenty-six (41.9%) patients developed AOSD at age ≥ 65 years. The elderly onset group had a lower frequency of sore throat (53.8% vs. 86.1%), higher frequency of pleuritis (46.2% vs. 16.7%), and higher complication rates of disseminated intravascular coagulation (30.8% vs. 8.3%) and macrophage activation syndrome (19.2% vs. 2.8%) than the younger onset group. Cytomegalovirus infections were frequent in elderly onset patients (38.5% vs. 13.9%) but decreased with early glucocorticoid dose reduction and increased immunosuppressant and tocilizumab use. Elderly AOSD is not uncommon; these patients have different characteristics than younger-onset patients. Devising a way to control disease activity quickly while managing infections may be an important goal in elderly AOSD.
成人Still 病(AOSD)——一种全身性炎症性疾病——通常发生在年轻时。最近,老年发病患者的比例一直在增加;然而,相关数据有限。为了评估多中心队列中老年 AOSD 患者的特征,我们回顾性分析了 2008 年 4 月至 2020 年 12 月期间五家医院的 62 例 AOSD 患者。根据发病时的年龄将患者分为两组:年轻发病组(≤64 岁)和老年发病组(≥65 岁)。比较了两组的临床症状、并发症、实验室检查、治疗和结局。26 例(41.9%)患者在年龄≥65 岁时发生 AOSD。老年发病组咽痛发生率较低(53.8% vs. 86.1%),胸膜炎发生率较高(46.2% vs. 16.7%),弥漫性血管内凝血并发症发生率较高(30.8% vs. 8.3%)和巨噬细胞活化综合征发生率较高(19.2% vs. 2.8%)。老年发病组巨细胞病毒感染较为常见(38.5% vs. 13.9%),但随着糖皮质激素剂量的早期减少以及免疫抑制剂和托珠单抗的使用增加,感染减少。老年 AOSD 并不少见;这些患者与年轻发病患者的特征不同。在老年 AOSD 中,快速控制疾病活动而同时管理感染可能是一个重要的目标。